Overview :: Rezolute, Inc. (RZLT)

Investor Relations Overview

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.

Corporate Presentation

Stock Snapshot

RZLT Symbol

OTCQB Market

Price

Change

Volume

View Detailed Stock Data

View IR Calendar

Upcoming Events

October 28, 2019 • 3:00pm PT

Special Meeting of the Stockholders

Recent News

Oct 11, 2019 Rezolute Management to Present at 2019 BIO Investor Forum Conference
Aug 5, 2019 Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
Jul 24, 2019 Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option

View Press Releases

AntriaBio

Investors

Overview

Investor Relations Overview

Corporate Presentation

Stock Snapshot

Upcoming Events

Recent News